Market Overview

Patterson Companies Reports Fiscal 2020 Second-Quarter Operating Results

Share:
  • Second-quarter reported net sales increased 1.0 percent to $1.42 billion, and internal sales increased 1.9 percent.
  • Adjusted operating margin increased year-over-year by 40 bps to 4.0 percent.
  • Dental segment internal sales increased 4.2 percent driven by strong equipment sales, improving trends in consumables and value-added services performance.
  • Animal Health segment internal sales increased 0.7 percent as strong Companion Animal performance offset macro challenges in the Production Animal business. 
  • Company made significant progress toward the resolution of legal matters and recorded reserve for agreement in principle with the U.S. Attorney's Office for the Western District of Virginia.
  • Delivered second-quarter GAAP loss of $0.35 per diluted share and adjusted earnings1 of $0.39 per diluted share.
  • Updates GAAP earnings guidance range to $0.42 to $0.52 per diluted share, including the impact of the legal reserve.
  • Raises adjusted earnings1 guidance range to $1.36 to $1.46 per diluted share.

Patterson Companies, Inc. (NASDAQ:PDCO) today reported consolidated net sales of approximately $1.42 billion (see attached Sales Summary for further details) in its fiscal second quarter ended October 26, 2019, an increase of 1.0 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and changes in product selling relationships, increased 1.9 percent.

Reported net loss attributable to Patterson Companies, Inc. for the second quarter of fiscal 2020 was $33.1 million, or $0.35 per diluted share, compared to net income attributable to Patterson Companies, Inc. of $28.9 million, or $0.31 per diluted share, in the second quarter of fiscal 2019. During the quarter Patterson recorded a reserve of $58.3 million related to the agreement in principle with the U.S. Attorney's Office for the Western District of Virginia's ("USAO-WDVA") investigation into the sales of prescription animal health products.

Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization costs, integration and business restructuring expenses, legal reserve expenses and accelerated debt issuance costs, totaled $36.6 million for the second quarter of fiscal 2020, or $0.39 per diluted share, compared to $36.3 million in the same quarter of fiscal 2019, or $0.39 per diluted share.

"Patterson's continued revenue growth and improved profitability in the second quarter underscore the traction we're gaining from our ongoing actions to drive performance improvement," said Mark Walchirk, President and CEO of Patterson Companies. "We continue to focus on building upon our momentum to grow our business on the top and bottom line, invest for the future and deliver enhanced value for our customers and shareholders. As a result of the progress we have made against our strategic priorities during the first two quarters of fiscal 2020, we are raising our adjusted earnings guidance for the year."

Patterson Animal Health

Reported net sales in our Animal Health segment for the second quarter of fiscal 2020, which comprised approximately 60 percent of the company's total sales, were $848.2 million compared to $855.4 million in the second quarter of last year. Internal sales for the segment increased 0.7 percent from the fiscal 2019 second quarter.

Patterson Dental

Reported net sales in our Dental segment for the second quarter of fiscal 2020, which represented approximately 40 percent of total company sales, were $564.6 million compared to $542.5 million in the second quarter of last year. Internal sales increased 4.2 percent compared to the fiscal 2019 second quarter.

Balance Sheet and Capital Allocation

During the first six months of fiscal 2020 Patterson Companies used $14.7 million of cash from operating activities and collected deferred purchase price receivables of $212.3 million, netting $197.7 million in cash, compared to a total of $365.8 million in the first six months of fiscal 2019. However, the previous year contained the initiation of the trade accounts receivable facility in the amount of $171.0 million. On an adjusted free cash flow1 basis, cash generated year-to-date in fiscal 2020 is $2.1 million higher than the year ago period.

In the second quarter of fiscal 2020, Patterson Companies paid $25.0 million in cash dividends to shareholders. On a year-to-date basis, Patterson has returned $50.5 million in cash dividends to shareholders.

Year-to-Date Results

Consolidated reported net sales for the first six months of fiscal 2020 totaled $2.75 billion, a 0.2 percent year-over-year increase. Internal sales have increased 1.2 percent compared to the first six months of fiscal 2019. Reported net loss attributable to Patterson Companies, Inc. was $3.1 million, or $0.03 per diluted share, compared to net income attributable to Patterson Companies, Inc. of $24.4 million, or $0.26 per diluted share in last year's period. The year-over-year decline is attributable to the increase in legal reserves, partially offset by an investment gain. Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization costs, integration and business restructuring costs, legal reserve expenses, accelerated debt issuance costs and an investment gain, totaled $62.0 million, or $0.65 per diluted share, compared to adjusted net income attributable to Patterson Companies, Inc. of $60.3 million, or $0.65 per diluted share, in the year-ago period.

Legal Updates

Patterson recently reached an agreement in principle with the USAO-WDVA that the Company understands will resolve the government's investigation into Animal Health International's sales of prescription animal health products to certain persons and/or locations not licensed to receive them, and other non-compliant licensing, dispensing, distribution and related sales processes disclosed by the Company during the investigation. Patterson continues to cooperate fully with the government, in addition to conducting its own internal, company-wide investigation into licensing, dispensing, distribution and related sales practices and shared its findings with the government. Patterson's investigation resulted in modifications of the Company's processes that are designed to drive compliance with relevant regulations.

Under the terms of the agreement in principle with the USAO-WDVA, Patterson's subsidiary, Animal Health International, Inc., will pay a total fine and forfeiture of $52.8 million and plead guilty to a strict-liability misdemeanor offense under the Federal Food, Drug and Cosmetic Act in connection with the failure to comply with federal law relating to the sales of prescription animal health products. In addition, Patterson and Animal Health International will enter into a Non-Prosecution Agreement. The agreement in principle with the USAO-WDVA is subject to negotiation of final terms, approval by all necessary parties, execution of definitive documents, and court approval. Upon reaching this agreement in principle with the USAO-WDVA, Patterson recorded a reserve of $58.3 million in its Corporate segment for the three and six months ended October 26, 2019 to account for the anticipated settlement of this matter and certain related costs and expenses.

As previously announced in November 2019, Patterson reached a settlement agreement with the Federal Trade Commission ("FTC") regarding an administrative complaint filed by the FTC concerning alleged conduct in 2013 related to the company's willingness to negotiate with "buying groups." Patterson continues to categorically deny any wrongdoing, but for business reasons, determined that a settlement is in its best interest, and allows the company to avoid further costs, distraction and uncertainty. As a result of the settlement, Patterson and the FTC agreed not to appeal the initial recommendation of the Administrative Law Judge ("ALJ") and Patterson agreed to abide by the terms of the ALJ's proposed remedial order, which did not impose any monetary fine on the company or require an outside monitor. As part of the settlement, Patterson agreed to maintain its ongoing personnel training on antitrust laws and to continue making independent decisions with regard to "buying groups."

"Patterson has made significant progress toward the resolution of legal matters facing the Company and has implemented substantial enhancements to its compliance program. As a result, Patterson is in an even stronger position to execute on our strategic goals," said Walchirk. "Importantly, we do not expect any changes to our capital allocation strategy as a result of the agreement in principle with the U.S. Attorney's Office for the Western District of Virginia."

FY2020 Guidance

Patterson Companies today updated its fiscal 2020 earnings guidance, which is provided on both a GAAP and non-GAAP adjusted1 basis:

  • GAAP earnings are now expected to be in the range of $0.42 to $0.52 per diluted share.
  • Non-GAAP adjusted earnings1 are now expected to be in the range of $1.36 to $1.46 per diluted share.
  • Our non-GAAP adjusted earnings1 guidance excludes the after-tax impact of:

- Deal amortization expenses of approximately $28.2 million ($0.30 per diluted share).

- Integration and business restructuring expenses of approximately $7.3 million ($0.08 per diluted share).

- Legal reserve expenses of approximately $72.4 million ($0.76 per diluted share).

- Accelerated debt issuance costs of approximately $1.5 million ($0.02 per diluted share).

- Accelerated derivative amortization expense of approximately $6.0 million ($0.06 per diluted share).

- Investment gain of approximately $26.5 million ($0.28 per diluted share).

Our guidance is for current operations as well as completed or previously announced acquisitions and does not include the impact of potential future acquisitions or similar transactions, if any, or impairments and material restructurings beyond those previously publicly disclosed. Our guidance assumes North American and international market conditions similar to those experienced in fiscal 2019.

1Non-GAAP Financial Measures

The Reconciliation of GAAP to non-GAAP Measures table appearing behind the accompanying financial information is provided to adjust reported GAAP measures, namely operating income, income before taxes, income tax expense, net income, net income attributable to Patterson Companies, Inc. and diluted earnings per share attributable to Patterson Companies, Inc., for the impact of deal amortization, integration and business restructuring expenses, legal reserve costs, accelerated debt issuance costs and an investment gain, along with the related tax effects of these items.

The term "adjusted free cash flow" used in this release is defined as net cash provided by (used in) operating activities less capital expenditures less the one-time benefit from the fiscal 2019 initiation of our trade account receivables facility plus collection of deferred purchase price receivables.

In addition, the term "internal sales" used in this release represents net sales adjusted to exclude foreign currency impact and changes in product selling relationships. Foreign currency impact represents the difference in results that is attributable to fluctuations in currency exchange rates the company uses to convert results for all foreign entities where the functional currency is not the U.S. dollar. The company calculates the impact as the difference between the current period results translated using the current period currency exchange rates and using the comparable prior period's currency exchange rates. The company believes the disclosure of net sales changes in constant currency provides useful supplementary information to investors in light of significant fluctuations in currency rates.

Management believes that these non-GAAP measures may provide a helpful representation of the company's second-quarter performance and earnings guidance, and enable comparison of financial results between periods where certain items may vary independent of business performance. These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding, similarly captioned, GAAP measures.

Second-Quarter Conference Call and Replay

Patterson Companies' fiscal 2020 second-quarter earnings conference call will start at 10 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on the Patterson Companies website. A replay of the fiscal 2020 second-quarter conference call can be heard for one week at 800-585-8367 and by providing the Conference ID 3799444 when prompted.

About Patterson Companies, Inc.

Patterson Companies, Inc. (NASDAQ:PDCO) is a value-added distributor serving the dental and animal health markets.

Dental Market

Patterson's Dental segment provides a virtually complete range of consumable dental products, equipment and software, turnkey digital solutions and value-added services to dentists and dental laboratories throughout North America.

Animal Health Market

Patterson's Animal Health segment is a leading distributor of products, services and technologies to both the production and companion animal health markets in North America and the U.K.

This press release contains certain forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements are information of a non-historical nature and are subject to risks and uncertainties that are beyond Patterson's ability to control. Forward-looking statements generally can be identified by words such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. It is uncertain whether any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do, what impact they will have on the results of operations and financial condition of Patterson or the price of Patterson stock. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those indicated in such forward-looking statements. Such risks and uncertainties include, without limitation, operations disruptions attributable to our enterprise resource planning system implementation; our ability to attract or retain qualified sales representatives and service technicians who relate directly with our customers; the reduction, modification, cancellation or delay of purchases of innovative, high-margin equipment; material changes in our purchasing relationships with suppliers; changes in general market and economic conditions; and the other risks and important factors contained and identified in Patterson's filings with the Securities and Exchange Commission, such as its Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, any of which could cause actual results to differ materially from the forward-looking statements. Any forward-looking statement in this press release speaks only as of the date on which it is made. Except to the extent required under the federal securities laws, Patterson does not intend to update or revise the forward-looking statements.

PATTERSON COMPANIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
(Unaudited)
 
Three Months Ended Six Months Ended
October 26,
2019
October 27,
2018
October 26,
2019
October 27,
2018
 
Net sales

$

1,418,744

 

$

1,404,752

 

$

2,747,395

 

$

2,741,072

 

 
Gross profit

 

301,494

 

 

295,076

 

 

591,548

 

 

578,739

 

 
Operating expenses

 

319,640

 

 

253,860

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com